多种生物标志物可预测冠状动脉慢性全闭症患者的主要心血管不良事件
一个新的血液生物标志物小组有效预测冠状动脉慢性全闭症 (CTO) 患者的心血管事件. 该工具有助于评估CTO患者的长期预后,改善风险分层和患者护理.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 预测医学是一种预测医学.
背景情况:
- 预测冠状动脉慢性全闭症 (CTO) 患者的长期预后仍然具有挑战性,因为工具有限.
- 心血管 (CV) 事件对患有CTO的个人构成重大风险.
结论:
- 一个多生物标志物小组可以有效地帮助评估冠状动脉CTO患者的不良结果风险.
- 这些发现对改进患者管理策略和丰富CTO人群临床试验有潜在的影响.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
